| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.061 | 0.4 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |